Ropivacaine (mixed presentations): Hospital supply issue

Last Updated: 24 July 2026

Supply issue Hospital only Active

This issue affects seven presentations of Ropivacaine Kabi.

Affected product

Because of constraints in the manufacturing plant, Fresenius Kabi has limited supplies of some ropivacaine presentations. Shipments continue to arrive, however supply continues to be constrained. The most affected products, as at 24 July 2026, are as follows.

Presentation	Pharmacode	Supply status	Next shipment
2 mg/ml, 100 ml bag	2479125	Available	to be confirmed
2 mg/ml, 200 ml bag	2479117	Limited stock available	to be confirmed
2mg/ml, 20 ml amp	2478714	Available	mid-August
7.5mg/ml 10 ml amp	2478722	Limited stock available	late-August
7.5mg/ml 20 ml amp	2478730	Available	to be confirmed
10mg/ml 10 ml amp	2478749	Available	late-August
10mg/ml 20 ml amp	2478765	Available	to be confirmed

Shipments

The dates given in the table are for when stock arrives in New Zealand. The product will still need to clear standard quality control processes before being released. Fresenius Kabi is working to make that process as quick as possible.

The next shipments listed will not resolve the issue completely. We are continuing to monitor the situation and will keep this page up to date.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.